Real‐world incidence and risk factors of level 3 (severe) hypoglycaemia in adults with type 1 or 2 diabetes ( <scp>iNPHORM</scp> , United States)
Level 3 hypoglycaemia remains common in T1D and T2D. Findings support risk-targeted prevention and diabetes care strategies that co-prioritize safety and effectiveness.
Authors
- Rozalina Grubina McCoy (ORCID: https://orcid.org/0000-0002-2289-3183)
- Bridget Ryan (ORCID: https://orcid.org/0000-0001-9080-5635)
- Alexandria Ratzki‐Leewing (ORCID: https://orcid.org/0000-0002-9474-7900)
- Jason Black (ORCID: https://orcid.org/0000-0002-3762-3231)
- Yu Kuei Lin (ORCID: https://orcid.org/0000-0003-1988-7046)
- Shuo Jim Huang (ORCID: https://orcid.org/0000-0002-4474-463X)
- Stewart B. Harris (ORCID: https://orcid.org/0000-0002-1794-6551)
- Guangyong Zou (ORCID: https://orcid.org/0000-0001-5773-4185)
- Jasminder Bhatti (ORCID: https://orcid.org/0009-0005-2313-2860)
Institutions
- Western University (CA)
- University of Maryland, Baltimore (US)
- University of Michigan (US)
- Foundation for the National Institutes of Health (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1111/dom.70252
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases